Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Connecting small molecules to nuclear receptor pathways.

Kristina Hettne1, Montserrat Cases, Scott Boyer

  • 1Safety Assessment, AstraZeneca R&D, 43183 Mölndal, Sweden.

Current Topics in Medicinal Chemistry
|September 28, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How many protein pairs can we chemically target?

Drug discovery today·2026
Same author

ChemBang: Expanding the Chemical Space Around Small Molecules.

Molecular informatics·2026
Same author

SAFR: Enabling Fragment-Based Drug Discovery with a Synthetic Binding Pose Data Set.

Journal of chemical information and modeling·2026
Same author

Sexual Dysfunctions Associated with Proton Pump Inhibitors: Insights from VigiBase, the World Health Organization Pharmacovigilance Database.

Drug safety·2025
Same author

Enhancing molecular property prediction through data integration and consistency assessment.

Journal of cheminformatics·2025
Same author

Influence of differential source patterns in the detection of signals of disproportionate reporting for PARP inhibitors.

Frontiers in drug safety and regulation·2025

Connecting small molecules to target proteins and biological pathways is crucial for drug discovery. Understanding target selectivity in promiscuous pathways improves drug efficacy and reduces toxicity.

Area of Science:

  • Pharmacology
  • Chemical Biology
  • Drug Discovery

Background:

  • Efforts to link small molecules to target proteins are ongoing, utilizing bibliographic data for annotated chemical libraries.
  • Connecting molecules to biological pathways, especially those involving nuclear receptors, is a key area of research.

Purpose of the Study:

  • To connect small molecules to biological pathways, focusing on nuclear receptor family members.
  • To investigate the importance of molecular selectivity for targets with inherent pathway promiscuity.
  • To highlight implications for drug discovery, addressing efficacy and toxicity challenges.

Main Methods:

  • Extraction of pharmacological data from bibliographic sources.
  • Creation of annotated chemical libraries linking small molecules to target proteins.

Related Experiment Videos

  • Annotation process connecting molecules to biological pathways, with a focus on nuclear receptors.

    • Main Results:

    • Demonstrated the significance of molecular selectivity for targets exhibiting pathway promiscuity.
    • Highlighted the impact of this selectivity on improving drug efficacy and reducing toxicity.
    • Identified limitations in the molecule-to-target-to-pathway annotation process.

    Conclusions:

    • Target selectivity is critical for drug discovery, particularly with promiscuous targets.
    • Improved molecule-to-pathway annotations can enhance drug development outcomes.
    • Addressing annotation limitations is essential for advancing pharmacological research.